Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from August 2022.
Pharmaceuticals
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: Proposed Amendments Would Make Foreign Investment in India’s Biological Resources Easier Proposed Amendments Would Make Foreign Investment in India’s Biological Resources Easier
Indian lawmakers are currently debating amendments that would make it easier for foreign investors to develop products from native biological resources.
-
Read more: Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA
While it may not seem controversial to promote honesty before the USPTO, a recent Federal Register Notice goes far beyond requiring candor.
-
Read more: Everything You Wanted to Know About Expanded Access but Were Afraid to Ask, Part 1 Everything You Wanted to Know About Expanded Access but Were Afraid to Ask, Part 1
Expanded access allows patients who lack other treatment options to try unapproved medical products in development.
-
Read more: Reclaiming Global Public Health Reclaiming Global Public Health
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
-
Read more: Can Children Consent to the COVID Vaccine? The Case of Foster Care and Juvenile Justice Can Children Consent to the COVID Vaccine? The Case of Foster Care and Juvenile Justice
Can young people consent to COVID-19 vaccinations?
-
Read more: A Response to ‘Another Legislative Attempt to Revive Gene Patenting’ A Response to ‘Another Legislative Attempt to Revive Gene Patenting’
Including purified and isolated materials as eligible subject matter under 35 U.S.C. § 101 can benefit patients, researchers, and innovation.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from July 2022.
-
Read more: Many Hospitals Receiving Discounted Drugs May Not Offer Patients Pharmaceutical Assistance Many Hospitals Receiving Discounted Drugs May Not Offer Patients Pharmaceutical Assistance
There are no measures built into the 340B program to assure that discounts are being used to support care for low-income populations.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from June 2022.
